L-DOPA Powder

Product name: L dopa
Plant Source: a leguminous plant
Specification: Levodopa 98%
Test Method: HPLC
CAS Registry No: 59-92-7
Appearance: White powder
Certifications: ISO, HACCP, HALAL, KOSHER, Technical Invention Patent Certificate
MOQ: 1KG
Sample: Free sample available
Production Capacity: 1000KG/month
Delivery Time: Delivery within one day from warehouse
Shelf Life: Three years
Payment: Multiple terms acceptable like T/T, LC, DA
Company Advantage: Kintai mainly focuses on the production of high content plant extracts and pharmaceutical intermediates all the year round
  • Fast Delievery
  • Quality Assurance
  • 24/7 Customer Service

Product Introduction

Product Details


Healthkintai® is a leading supplier of high-purity L-Dopa powder, the essential precursor to dopamine that plays a vital role in neurological health. Clinically, levodopa serves as the most effective dopamine replacement therapy for managing Parkinson's disease, particularly in addressing the hallmark symptom of bradykinesia and significantly enhancing patients' quality of life. When other anti-Parkinson medications prove insufficient in controlling symptoms, physicians typically turn to levodopa as the therapeutic mainstay. Beyond idiopathic Parkinson's, this compound also demonstrates efficacy in treating post-encephalitic parkinsonism and cases of symptomatic parkinsonism resulting from carbon monoxide exposure.

Emerging research suggests levodopa may offer neuroprotective benefits, potentially slowing disease progression in Parkinson's patients and providing lasting improvements even after treatment cessation. The therapeutic applications of levodopa extend to off-label uses, including management of restless legs syndrome and periodic limb movement disorder during sleep. For patients experiencing intermittent restless legs symptoms that don't require continuous daily medication, levodopa presents a viable treatment alternative.At KINTAI, we derive our premium levodopa powder from Mucuna macrocarpa Wall seeds, a leguminous plant source renowned for its high natural L-Dopa content. Our commitment lies in delivering pharmaceutical-grade L-Dopa to support both clinical applications and research initiatives in neurological health. Through stringent quality control and sustainable sourcing practices, we ensure reliable access to this critical therapeutic compound for healthcare providers and researchers worldwide.

As a trusted partner in neurological health solutions, KINTAI remains dedicated to advancing treatment options and improving patient outcomes through our high-quality L-Dopa products. Our expertise in extraction and purification processes guarantees consistent potency and purity, meeting the exacting standards required for both medical and research applications. We continue to invest in innovative production methods and scientific collaborations to further enhance the therapeutic potential of this vital neurological compound.

 

 L dopa Product quality specification & standard 

 

 

CAS Number 59-92-7 Molecular Weight 197.188
Density 1.5±0.1 g/cm3 Boiling Point 448.4±45.0 °C at 760 mmHg
Molecular Formula C9H11NO4 Melting Point 276-278 °C(lit.)
Common Name Levodopa Flash Point 225.0±28.7 °C

 

 Physical & chemical properties -Buy L dopa 

 

Product name

L-dopa Powder

Extract source

Litsea bean seed

Extraction Solvent

Ethyl alcohol

Appearance

White powder

Solubility

Dissolve in water

Identification

TLC , HPLC

Sulphated Ash

NMT 0.5%

Heavy metals

NMT 20 PPM

Loss On Drying

NMT 5.0%

Powder size

80Mesh, NLT90%

Assay of Natural L Dopa (HPLC test, percent, Standard in House)

Min. 95.0%

Residual Solvents

 

- N-hexane

NMT 290 PPM

- Methanol

NMT 3000 PPM

- Acetone

NMT 5000 PPM

- Ethyl Acetate

NMT 5000 PPM

- Ethanol

NMT 5000 PPM

Pesticide Residues

 

- Total DDT (Sum of p,p'-DDD,P,P'-DDE,o,p'-DDT and p,p' -DDT)

NMT 0.05 PPM

- Aldrin, Endrin, Dieldrin

NMT 0.01 PPM

Microbiological Quality (Total viable aerobic count)

 

- Bacteria, CFU/g, not more than

NMT 103

- Moulds and yeasts, CFU/g, not more than

NMT 102

- E.coli, Salmonella, S. aureus, CFU/g

Absence

Storage

In Tight, Light-resistant and Dry Place. Avoid Direct Sunshine. 

Shelf life

24 months

 


Interested?We'd love to send you a free Sample!


 Benefits -Buy L dopa Powder 

 

Core Strengthening Exercises for Parkinson's Disease - Part 4 of 4 - Davis  Phinney Foundation

1. Core Treatment for Parkinson's Disease

 

L-DOPA powder is one of the most effective medications for Parkinson's disease, a condition caused by the degeneration of dopamine-producing neurons in the brain's substantia nigra, leading to insufficient dopamine levels. By crossing the blood-brain barrier and converting into dopamine (via dopa decarboxylase), it replenishes depleted dopamine, significantly alleviating motor symptoms such as tremors, muscle rigidity, and bradykinesia, thereby improving patients' mobility and quality of life.

 

2. Efficacy in Other Dopamine-Related Movement Disorders

Beyond Parkinson's disease, L-DOPA is beneficial for other conditions linked to dopamine deficiency:

Parkinsonism: It helps manage symptoms (similar to Parkinson's) caused by factors like certain medications, infections, or cerebrovascular diseases.

Dopa-responsive dystonia: A rare hereditary disorder where even low doses of L-DOPA effectively reduce abnormal muscle tone, including spasms and postural irregularities, due to the body's heightened sensitivity to the drug.

 

3. Potential Neuroprotective Research Significance

 

While its primary clinical role is dopamine replacement, L-DOPA has garnered interest in neuroprotective studies. Animal research suggests it may protect damaged dopaminergic neurons by regulating neuronal metabolism, reducing oxidative stress, or supporting cellular function. However, this area remains under investigation, and its exact mechanisms and clinical relevance in humans are not yet fully established.

It is critical to note that L-DOPA is a prescription medication, requiring strict medical supervision due to potential side effects (e.g., nausea, vomiting, dyskinesia), with dosages tailored to individual patient needs.

​​​​​​​

 Applications -Buy L dopa Powder

 

 

1. Therapeutic Use in Parkinson's Disease and Related Movement Disorders

L-DOPA powder has a well - established and crucial application in the treatment of Parkinson's disease. Parkinson's is a neurodegenerative disorder mainly caused by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. This leads to a significant reduction in dopamine levels, resulting in symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability.

 

As the metabolic precursor of dopamine, L-DOPA can cross the blood - brain barrier. Once in the brain, it is decarboxylated by the enzyme dopa decarboxylase to form dopamine. By replenishing the depleted dopamine in the brain, L-DOPA effectively alleviates the motor symptoms of Parkinson's disease. It has been the cornerstone of Parkinson's treatment for decades, allowing patients to regain better control over their movements and significantly enhancing their quality of life. For example, many patients who were previously severely restricted in their daily activities due to Parkinson's symptoms can experience improved mobility, the ability to perform tasks like dressing, eating, and walking more independently after starting L-DOPA treatment.

 

In addition to idiopathic Parkinson's disease, L-DOPA is also used to manage various forms of parkinsonism. Drug - induced parkinsonism, which can be caused by medications such as certain antipsychotics, can often be mitigated with L-DOPA. Vascular parkinsonism, resulting from cerebrovascular disease, may also show some improvement in motor function with L-DOPA treatment. Moreover, L-DOPA is highly effective in treating dopa - responsive dystonia, a rare genetic disorder. Even small doses of L-DOPA can lead to dramatic and long - lasting relief of symptoms in patients with this condition, which is characterized by involuntary muscle contractions and abnormal postures.

2. Potential Applications in Neurodegenerative and Neuropsychiatric Research

Levodopa powder plays a significant role in research related to neurodegenerative and neuropsychiatric conditions. In neurodegenerative diseases other than Parkinson's, such as Huntington's disease, there is growing interest in understanding the role of dopamine and L-DOPA. Huntington's is characterized by the progressive degeneration of neurons in the brain, and dopamine dysregulation is thought to contribute to some of its symptoms. L-DOPA is being studied to see if it can modulate the dopamine system in a way that might slow down the disease progression or alleviate certain symptoms, although this is still in the experimental stage.

 

For restless legs syndrome (RLS), a common neurological disorder causing uncomfortable sensations in the legs and an irresistible urge to move them, especially at rest, L-DOPA has shown potential in some cases. It may help by influencing the dopamine - related neural pathways that are thought to be disrupted in RLS. However, long - term use of L-DOPA in RLS can lead to augmentation, a phenomenon where the symptoms worsen and spread over time, so its use in this context requires careful monitoring and further research.

 

In the field of neuropsychiatry, L-DOPA is also being investigated in relation to certain symptoms of schizophrenia. While schizophrenia is primarily associated with abnormal dopamine function in the brain, the role of L-DOPA is complex. Some studies suggest that in specific subgroups of schizophrenia patients with certain dopamine - related deficits, L-DOPA might be used to fine - tune the dopamine system and potentially improve symptoms. However, this area is highly controversial and still under intense research, as improper modulation of dopamine in schizophrenia can also lead to exacerbation of symptoms.

Neurodegenerative and Neuropsychiatric ResearchKINTAI

3. Investigations in Cognitive and Athletic Performance 

There have been some controversial investigations into the potential of L-DOPA powder to enhance cognitive and athletic performance. Dopamine, which L-DOPA is converted into, plays a role in the brain's reward system, motivation, and attention. Some researchers have explored whether L-DOPA could be used to improve cognitive function in healthy individuals, such as enhancing memory, attention span, or mental processing speed. However, the results have been inconsistent, and there are concerns about potential negative impacts on the delicate balance of neurotransmitter systems in the brain.

 

In the realm of athletics, L-DOPA has been studied for its possible performance - enhancing effects. Since dopamine is involved in motor control and the body's response to exercise, there was speculation that increasing dopamine levels through L-DOPA might improve muscle strength, endurance, or reaction time. However, such uses are not only unregulated but also pose significant health risks. L-DOPA can cause a variety of side effects, including nausea, vomiting, changes in blood pressure, and abnormal involuntary movements (dyskinesias). Additionally, using L-DOPA for performance enhancement in sports is unethical and violates anti - doping regulations, as it gives an unfair advantage to athletes.

 


Interested?We'd love to send you a free Sample!


 KINTAI Levodopa Powder Process Flow 

KINTAI‘s Production Process Flow

 

 HPLC Analysis --Buy Levodopa 

 

 

 

 

Figour1.HPLC Chromatogram of the acid extract of Mucuna pruriens seeds obtained by high-performance liquid chromatography. The highest peak indicates the presence of levodopa. 

HPLC Chromatogram of the acid extract of Mucuna pruriens seeds obtained by high-performance liquid chromatography. The highest peak indicates the presence of levodopa. 

Figour2.HPLC of Levodopa standard chromatogram obtained by high-performance liquid chromatography. The highest peak indicates the presence of levodopa. 

HPLC of Levodopa standard chromatogram obtained by high-performance liquid chromatography. The highest peak indicates the presence of levodopa. 

 


Interested?We'd love to send you a free Sample!


​​​​​​​

 

 Buy KINTAI levodopa Safety 

 

 

1. Safety in Clinical Use Depends on Standardized Administration​

As a dopamine precursor drug, KINTAI L-DOPA has its safety clinically validated under the premise of strictly following medical advice. In the treatment of Parkinson's disease and related movement disorders, reasonable dosage adjustments (usually in combination with peripheral decarboxylase inhibitors such as carbidopa) can reduce gastrointestinal side effects like nausea and vomiting, as well as cardiovascular reactions (such as orthostatic hypotension). Clinical data show that most patients can tolerate the treatment with standardized medication, and the incidence of serious adverse reactions is low. However, it should be noted that long-term use may lead to dyskinesias (involuntary movements), end-of-dose phenomena, etc., which need to be optimized through individualized regimens to reduce risks.​

2. Contraindications and Cautious Use Scenarios Must Be Strictly Controlled​

The safety of KINTAI L-DOPA is closely related to the individual conditions of patients, and there are clear contraindications and cautious use situations:​

·Contraindicated populations include those allergic to L-DOPA, patients with angle-closure glaucoma (which may increase intraocular pressure), and patients with severe mental illness (which may induce or aggravate symptoms such as hallucinations and delusions);​

·Populations requiring caution include those with hepatic or renal insufficiency (drug metabolism may be affected), patients with heart disease (heart rate and blood pressure fluctuations need to be monitored), and pregnant or lactating women (insufficient safety data, requiring risk assessment before use).​

Avoiding these scenarios is key to preventing potential safety hazards.​

3. Management of Drug Interactions and Adverse Reactions​

The safety of KINTAI L-DOPA is affected by combined medication, and attention should be paid to drug interactions:​

·Combined use with monoamine oxidase inhibitors (MAOIs) may trigger hypertensive crisis, so an interval of at least 2 weeks is required between uses;​

·Antipsychotic drugs (such as haloperidol) may antagonize its efficacy and aggravate motor symptoms, so their combined use should be avoided.​

In addition, common adverse reactions (such as dizziness, insomnia, and loss of appetite) are mostly temporary and can be alleviated by starting with a small dose, increasing slowly, or combining with auxiliary drugs; if severe dyskinesias, psychiatric symptoms, or allergic reactions occur, timely discontinuation of the drug and medical intervention are required to ensure medication safety.​

Why Choose L Dopa Powder by Kintaihealth®?


1. We promise that our raw materials are naturally grown without any additives.
2. We provide customized extraction solutions to produce L Dopa powder in various specifications tailored to your requirements.
3. Our production facilities hold internationally recognized certifications including GMP, ISO 9001, ISO 22000, HACCP, KOSHER, and HALAL, guaranteeing the highest standards for your peace of mind.

 

KINTAI is a leading manufacturer and supplier of L Dopa powder. With our state-of-the-art research and development center, production facilities, multiple patents, and quality certifications, we ensure the highest standards of product quality. We support customized products and provide integrated service solutions. Our fast delivery and secure packaging guarantee a great customer experience. We provide free samples for testing, if you want to purchase high quality L Dopa Powder, please feel free to contact us at info@kintaibio.com

About Us


factory equipment

  KINTAI Certifications  

Our Certifications

  Packaging and Delivery  

Production Process

Packing and shipping

Send

You May Like

0